Evidence map›Paper›PMID 27148966›Full record

ArticlePloS one2016

Human Bacterial Artificial Chromosome (BAC) Transgenesis Fully Rescues Noradrenergic Function in Dopamine β-Hydroxylase Knockout Mice.

Joseph F Cubells, Jason P Schroeder, Elizabeth S Barrie, Daniel F Manvich, Wolfgang Sadee, Tiina Berg, Kristina Mercer, Taylor A Stowe, L Cameron Liles, Katherine E Squires and 5 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Role of Dopamine in the Heart in Health and Disease.International journal of molecular sciences · 2023
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Joseph F CubellsDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Jason P SchroederDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Elizabeth S BarrieCenter for Pharmacogenomics, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Daniel F ManvichDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Wolfgang SadeeCenter for Pharmacogenomics, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Tiina BergDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Kristina MercerDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Taylor A StoweDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, United States of America.
L Cameron LilesDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Katherine E SquiresDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Andrew MezherDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Patrick CurtinDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Dannie L PerdomoGraduate Program in Genetics and Molecular Biology, Emory University, Atlanta, Georgia, United States of America.
Patricia SzotMIRECC, VA Puget Sound Health Care System, Seattle, Washington, United States of America.
David WeinshenkerDepartment of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Emory University · USThe Ohio State University · USCenter for Autism and Related Disorders · USUniversity of Washington · US

Funding

Expression Genetics in Drug TherapyU01GM092655 · NIGMS · OHIO STATE UNIVERSITY · PI SADEE, WOLFGANG · 2010 to 2014
$8.6M
Training Program in Neurobiology of Drug AbuseT32DA015040 · NIDA · EMORY UNIVERSITY · PI KUHAR, MICHAEL J · 2003 to 2012
$3.6M
Effects of voluntary exercise on reinstatement of cocaine seekingR01DA027535 · NIDA · EMORY UNIVERSITY · PI HOLMES, PHILIP V, WEINSHENKER, DAVID · 2010 to 2014
$1.9M
Mechanisms of cocaine hypersensitivity following chronic DBH inhibition 5R01DA038453-02 Diversity SupplementR01DA038453 · NIDA · EMORY UNIVERSITY · PI PALADINI, CARLOS ANTONIO, WEINSHENKER, DAVID · 2015 to 2019
$1.8M
Translational analysis of functional variation in human dopamine beta?hydroxylaseR21NS072712 · NINDS · EMORY UNIVERSITY · PI CUBELLS, JOSEPH F. · 2011 to 2012
$422k
NIDA NIH HHS R01 DA027535NIDA NIH HHS R01 DA038453NIDA NIH HHS T32 DA015040NIGMS NIH HHS U01 GM092655NINDS NIH HHS R21 NS072712
6 · The paper itself

Abstract

Dopamine β-hydroxylase (DBH) converts dopamine (DA) to norepinephrine (NE) in noradrenergic/adrenergic cells. DBH deficiency prevents NE production and causes sympathetic failure, hypotension and ptosis in humans and mice; DBH knockout (Dbh -/-) mice reveal other NE deficiency phenotypes including embryonic lethality, delayed growth, and behavioral defects. Furthermore, a single nucleotide polymorphism (SNP) in the human DBH gene promoter (-970C>T; rs1611115) is associated with variation in serum DBH activity and with several neurological- and neuropsychiatric-related disorders, although its impact on DBH expression is controversial. Phenotypes associated with DBH deficiency are typically treated with L-3,4-dihydroxyphenylserine (DOPS), which can be converted to NE by aromatic acid decarboxylase (AADC) in the absence of DBH. In this study, we generated transgenic mice carrying a human bacterial artificial chromosome (BAC) encompassing the DBH coding locus as well as ~45 kb of upstream and ~107 kb of downstream sequence to address two issues. First, we characterized the neuroanatomical, neurochemical, physiological, and behavioral transgenic rescue of DBH deficiency by crossing the BAC onto a Dbh -/- background. Second, we compared human DBH mRNA abundance between transgenic lines carrying either a "C" or a "T" at position -970. The BAC transgene drove human DBH mRNA expression in a pattern indistinguishable from the endogenous gene, restored normal catecholamine levels to the peripheral organs and brain of Dbh -/- mice, and fully rescued embryonic lethality, delayed growth, ptosis, reduced exploratory activity, and seizure susceptibility. In some cases, transgenic rescue was superior to DOPS. However, allelic variation at the rs1611115 SNP had no impact on mRNA levels in any tissue. These results indicate that the human BAC contains all of the genetic information required for tissue-specific, functional expression of DBH and can rescue all measured Dbh deficiency phenotypes, but did not reveal an impact of the rs11115 variant on DBH expression in mice.

Indexed as

Gene Transfer TechniquesAdrenal GlandsAdrenergic NeuronsAnimalsBrain ChemistryChromosomes, Artificial, BacterialDopamineDopamine beta-HydroxylaseHumansIn Situ HybridizationMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMotor ActivityMyocardiumDopamineDopamine beta-HydroxylaseNorepinephrine

Identifiers

PMID27148966
PMCPMC4857931
OpenAlexW2371723430

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.